Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this month.

FDA's rising criticism: A response option

With an expanded staff and power, FDA 483 letters are expected to rise. Here's one option on how to avoid and respond to agency criticism.

Hp 19185 I Stock Warning And Risk

CEE Packaging, the Packaging Industry of Central and Eastern Europe, reports that a 10-step guide is available to help pharmaceutical processors, medical device manufacturers, and other life-sciences facilities respond appropriately within the permitted 15-day window of receiving a 483 letter from the agency. The guide, “How to Avoid and Respond to Public FDA Criticisms—Form 483 Letters—for Temperature, Humidity and other Controlled Environments,” comes from Veriteq.

CGMP.com provides some basics on FDA-issued warning letters.

Packaging World/Healthcare Packaging legal columnist Eric Greenberg recently discussed the agency's increasing activity. Read more about FDA, regulatory, and legal developments.

-Jim Butschli, Editor

Break out of the ordinary: see what’s new in life sciences packaging
At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us this month to experience a breakthrough for life sciences products.
REGISTER NOW!
Break out of the ordinary: see what’s new in life sciences packaging
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report